Revolution Dispensary – Maryville

Collinsville, IL

Revolution Dispensary – Moline

Moline, IL

Revolution Dispensary – Sunrise Beach

Sunrise Beach, MO

Enlightened Dispensary – Abingdon

Abingdon, MD

Enlightened Dispensary – Schaumburg

Schaumburg, IL

Enlightened Dispensary – Morrilton

Morrilton, AR

Enlightened Dispensary – Clarksville

Clarksville, AR

Enlightened Dispensary – Arkadelphia

Caddo Valley, AR

Enlightened Dispensary – Heber Springs

Heber Springs, AR

Enlightened Dispensary – Mount Prospect

Mt Prospect, IL

You’re shopping at:

Searching for nearby stores...

The capitol building at sunset with lights on and a clear sky.

A New Chapter: The DEA’s Historic Rescheduling of Cannabis

On April 30th, the DEA announced a big shift in American drug policy – the rescheduling of cannabis from a Schedule I to a Schedule III controlled substance. This decision marks a significant change in how cannabis is regulated, used, and thought of across the country. The historic decision acknowledges the medical use of cannabis and a lower potential for abuse compared to harder drugs like heroin and LSD, which remain Schedule I.

The History of Cannabis as a Controlled Substance

The DEA defines Schedule I substances as:

“…substances or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.”

Cannabis has been listed under this category since the Controlled Substances Act was enacted in 1970, despite public sentiment supporting its medicinal benefits and relatively low risk of abuse.

The DEA rescheduling marijuana to Schedule III, which includes drugs like ketamine and Testosterone that are acknowledged to have legitimate medical uses, is a significant move away from decades of tough regulation. This reflects a shift towards a more science-based approach to drug policy, influenced by increasing public and political advocacy for cannabis reform.

The DEA’s Decision Process

The recommendation to reclassify cannabis came from the U.S. Department of Health and Human Services. Longstanding clinical and anecdotal evidence support the medical benefits of cannabis and the need for a move away from the strict Schedule I designation. The DEA marijuana rescheduling proposal still requires review by the White House Office of Management and Budget and will undergo a public comment period before any changes are formally enacted.

This process ensures that decision-makers from various sectors can provide input on the potential impact of the rescheduling. The process underscores the caution that the federal government is taking to navigate this historic policy shift.

a opened jar filled with raw marijuana buds on a glass display case

Economic and Industry Impact

The economic implications of the DEA marijuana rescheduling proposal to Schedule III are significant. Cannabis businesses, previously held back by a lack of access to banking and financial services, may now experience more financial integration and stability.

This change could also attract new investors who were previously wary of the legal ambiguities and stringent tax burdens associated with cannabis businesses. The industry could see an influx of new investment, stimulating growth, innovation, and job creation within existing markets and new markets.

Medical Research and Healthcare

Rescheduling cannabis opens up new avenues for medical research by reducing the regulatory hurdles associated with studying Schedule I substances. Researchers will soon have more free access to cannabis, allowing for in-depth studies to determine its efficacy and safety across a range of medical conditions.

This will hopefully lead to a broader acceptance of cannabis in mainstream medicine and potentially spur the development of new pharmaceutical products derived from cannabis compounds. Healthcare professionals may soon have more freedom to prescribe cannabis-based treatments for a wider variety of medical conditions.

Learn more about illinois medical cannabis.

marijuana buds cannabis plant and handcuffs

Legal and Social Impact

Legally, the rescheduling of cannabis will likely reduce federal prosecutions for cannabis offenses. This aligns more with the growing number of states that have legalized medical and recreational cannabis not to mention non-psychoactive CBD products.

What is CBD?

Socially, many expect this change to further break down the stigma associated with cannabis use. Rescheduling is essentially a federal acknowledgment of its medical applications and lends legitimacy to what many people have known for years. This could also pave the way for more comprehensive reforms, such as addressing the disproportionate impact of cannabis prohibition on marginalized communities, expunging past convictions, and easing barriers to entry into the cannabis industry.

Federal vs. State Law Conflicts

While this decision is big news, the rescheduling of cannabis doesn’t change the ongoing conflict between federal law and state-level cannabis reforms. Many states have moved to fully legalize cannabis, but under federal law, it remains a controlled substance, although less restricted.

This conflict continues to create legal uncertainties for businesses and consumers. What’s more, the new Schedule III status might require revisions in state regulations to accommodate the federal shift, potentially leading to a patchwork of standards that could complicate compliance and enforcement.

cropped view of emotional girl pointing her finger at a

Challenges and Criticisms

Despite all the positivity from the cannabis community, the transition to Schedule III still has its critics. Some opponents argue that although rescheduling is progress, the DEA should de-scheduled cannabis entirely to reflect modern safety and cultural acceptance.

Others have expressed concern over potential increases in recreational use and the challenges the DEA might face in regulating a growing industry. There are also international obligations under certain treaties that pose some diplomatic challenges because they compel countries that have signed to strictly control cannabis.

Final Thoughts

This is a pivotal moment in U.S. drug policy, reflecting a societal shift towards a more nuanced understanding of the drug’s benefits and risks. The DEA marijuana rescheduling proposal will no doubt influence numerous areas of the industry, from healthcare and research to economics and criminal justice.

As the impact of this decision takes shape, it’s critical for policymakers, industry leaders, and the public to engage in informed dialogue and prepare for a brand-new landscape of cannabis regulation.


Drug Scheduling

US poised to ease restrictions on marijuana in historic shift, but it’ll remain controlled substance

General Cannabis FAQ

Cannabis, often referred to as marijuana, is a plant that has been used for thousands of years for various purposes, including medicine, textiles, and recreation. The plant contains compounds known as cannabinoids, with delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) being the most well-known. THC is primarily responsible for the plant’s psychoactive effects, while CBD is recognized for its potential therapeutic benefits without causing a “high.”

Many countries and U.S. states have decriminalized or legalized the use of marijuana for medical use, recreational, or both. The legal status changes frequently as legislation evolves.

In the U.S., states vote to regulate marijuana use on an individual basis. While it remains illegal at the federal level, numerous states have legalized it for medicinal and/or recreational use.

The following states have legalized medical, recreational, or both:

  • Alaska – Medical
  • Arizona – Legal
  • Arkansas – Medical
  • California – Legal
  • Colorado – Legal
  • Connecticut – Legal
  • Delaware – Legal
  • District of Columbia – Legal
  • Florida – Medical
  • Hawaii – Medical (Possession decriminalized for small amounts)
  • Illinois – Legal
  • Louisiana – Medical (Possession decriminalized for small amounts)
  • Maine – Legal
  • Maryland – Legal
  • Massachusetts – Legal
  • Michigan – Legal
  • Minnesota – Legal
  • Mississippi – Medical (Possession decriminalized for small amounts)
  • Missouri – Legal
  • Montana – Legal
  • Nevada – Legal
  • New Hampshire – Medical (Possession decriminalized for small amounts)
  • New Jersey – Legal
  • New Mexico – Legal
  • New York – Legal
  • North Dakota – Medical (Possession decriminalized for small amounts)
  • Ohio – Medical (Possession decriminalized)
  • Oklahoma – Medical
  • Oregon – Legal
  • Pennsylvania – Medical
  • Rhode Island – Legal
  • South Dakota – Medical
  • Utah – Medical
  • Vermont – Legal
  • Virginia – Legal
  • Washington – Legal
  • West Virginia – Medical


Outside of the U.S., countries like The Netherlands, Canada, and, more recently, Thailand have legalized cannabis on a national level.

Always check local laws and regulations in your specific location.

In states where marijuana has been legalized, you can purchase products at licensed dispensaries. Revolution products are available at Enlightened, Revolution, and partner dispensaries in Illinois, Arkansas, Missouri, and Maryland. Find a dispensary near you.

Keep in mind that dispensaries may cater to medical patients, recreational consumers, or both, depending on local laws.

Always ensure that you are buying from a reputable and licensed establishment to guarantee product quality and safety.

The effects of cannabis vary widely depending on the strain, dosage, method of consumption, an individual’s endocannabinoid system, and more.

Some commonly reported effects include:

Psychoactive Effects: Euphoria, mood elevation, cerebral stimulation, stress relief, calming effects, and relaxation.

Physical Effects: Pain relief, body buzz, anti-inflammation, anti-nausea, energy boost or sedation, and appetite stimulation

*Medical Benefits: Cannabis is believed to have a range of therapeutic effects and alleviation of symptoms related to conditions like epilepsy, PTSD, and more.

*Marijuana is not approved by the FDA to treat, cure, or prevent any disease.

The primary difference lies in their intended use:

Medical Cannabis: Used as a treatment and alleviation of symptoms for specific health conditions. Medical strains might be cultivated and processed to have higher CBD content or other therapeutic compounds. Medical cannabis requires a physician who usually prescribes or recommends it as a treatment option.

Recreational Cannabis: Used without a medical justification but for personal enjoyment and fulfillment.

The process varies from state to state but typically involves the following steps:

Doctor’s Recommendation: Schedule an appointment with a physician who is authorized to recommend medical marijuana. Discuss your health conditions and reasons for seeking cannabis as a treatment.

Application: Once you have a doctor’s recommendation, you’ll usually need to apply for a medical marijuana card through a designated state or country agency.

Proof & Identification: Provide necessary identification and proof of residency as required by your jurisdiction.

Fee Payment: Most jurisdictions require a fee for the application and issuance of a medical marijuana card.

Card Issuance: Once approved, you will receive your medical marijuana card, allowing you to purchase cannabis at designated medical dispensaries.

If you’d like more detailed information, please read our state-specific medical card guide here.